Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy-Reference-Cited by-同舟云学术

Microenvironment‐Responsive Prodrug‐Induced Pyroptosis Boosts Cancer Immunotherapy

Published:2021-10-27 Issue:24 Volume:8 Page:2101840
ISSN:2198-3844
Container-title:Advanced Science
language:en
Short-container-title:Advanced Science

Author:

Xiao Yao¹,Zhang Tian²,Ma Xianbin²,Yang Qi‐Chao¹,Yang Lei‐Lei¹,Yang Shao‐Chen¹,Liang Mengyun²,Xu Zhigang²^ORCID,Sun Zhi‐Jun¹^ORCID

Affiliation:

1. The State Key Laboratory Breeding Base of Basic Science of Stomatology (Hubei‐MOST) & Key Laboratory of Oral Biomedicine Ministry of Education School & Hospital of Stomatology Wuhan University Wuhan 430079 China

2. Key Laboratory of Luminescence Analysis and Molecular Sensing (Southwest University) Ministry of Education School of Materials and Energy & Chongqing Engineering Research Center for Micro–Nano Biomedical Materials and Devices Southwest University Chongqing 400715 China

Funder

National Natural Science Foundation of China

National Key Research and Development Program of China

Publisher

Wiley

Subject

General Physics and Astronomy,General Engineering,Biochemistry, Genetics and Molecular Biology (miscellaneous),General Materials Science,General Chemical Engineering,Medicine (miscellaneous)

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/advs.202101840

Reference43 articles.

1. Cancer immunoediting and resistance to T cell-based immunotherapy

2. Identification of Mutated Peptides in Bladder Cancer From Exomic Sequencing Data Reveals Negative Correlation Between Mutation-Specific Immunoreactivity and Inflammation

3. Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma

4. Immunogenic and tolerogenic cell death

5. Combination of chemotherapy and PD-1 blockade induces T cell responses to tumor non-mutated neoantigens

Cited by 213 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reductants supplement boost the antitumor efficacy of nanomedicine;Chemical Engineering Journal;2024-10

2. Applications of pyroptosis activators in tumor immunotherapy;Materials Today Bio;2024-10

3. Targeting RAC1 reactivates pyroptosis to reverse paclitaxel resistance in ovarian cancer by suppressing P21‐activated kinase 4;MedComm;2024-09

4. A Dual-pathway Pyroptosis Inducer Based on Au-Cu2-xSe@ZIF-8 Enhances Tumor Immunotherapy by Disrupting the Zinc Ion Homeostasis;Acta Biomaterialia;2024-09

5. AI-powered omics-based drug pair discovery for pyroptosis therapy targeting triple-negative breast cancer;Nature Communications;2024-08-30